Evaluating the Safety and Immunogenicity of Polyvalent DNA/gp120 HIV Vaccine in Healthy, HIV-uninfected Adults
Clinical trial NCT04927585 · COMPLETED
Trial details
- NCT number
- NCT04927585
- Sponsor
- Worcester HIV Vaccine
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-08
- Primary completion
- 2023-12-07
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.